Anixa Biosciences, Inc. (ANIX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Anixa Biosciences, Inc. (ANIX) closed at USD 2.66 on 2026-10-14, a change of -37.3 % over the past year, with a market capitalization of USD 96.64M.

Anixa Biosciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Anixa Biosciences, Inc. key figures

Previous close

USD 2.66 (2026-10-14)

1-year change

-37.3 %

Market cap

USD 96.64M

Enterprise value

USD 81.68M

P/E ratio (trailing)

-8.42

P/E ratio (forward)

-8.97

EPS (trailing)

-0.33

EPS (forward)

-0.31

PEG ratio

-0.11

Price to book

6.65

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.58

Employees

4

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Anixa Biosciences, Inc. and compare it with other stocks.